Dirk Hose

Bortezomib Induction and Maintenance Treatment in Patients With Newly Diagnosed Multiple Myeloma: Results of the Randomized Phase III HOVON-65/ GMMG-HD4 Trial

Pieter Sonneveld, Ingo Schmidt‐Wolf, Bronno van der Holt et al. · Journal of Clinical Oncology · 2012 · 826 citations · Full text

Medicine, Hematology, Pharmacotherapy +16

Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders

Andy C. Rawstron, Meral Beksaç, Ludmila Bezdîčková et al. · Haematologica · 2008 · 514 citations · Full text

Medicine, Hematology, Pathology +17

Administration of bortezomib before and after autologous stem cell transplantation improves outcome in multiple myeloma patients with deletion 17p

Kai Neben, Henk M. Lokhorst, Anna Jauch et al. · Blood · 2011 · 357 citations

Medicine, Hematology, Pharmacotherapy +15

Gene expression profiling for molecular classification of multiple myeloma in newly diagnosed patients

Annemiek Broyl, Dirk Hose, Henk M. Lokhorst et al. · Blood · 2010 · 338 citations · Full text

Life Sciences, Molecular Biology, Oncology +16

Target Expression, Generation, Preclinical Activity, and Pharmacokinetics of the BCMA-T Cell Bispecific Antibody EM801 for Multiple Myeloma Treatment

Anja Seckinger, Jose Antonio Delgado, Samuel Moser et al. · Cancer Cell · 2017 · 312 citations · Full text

Medicine, Oncology, Pharmacology +17